We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

159 hedge funds and large institutions have $1.13B invested in Cardiovascular Systems, Inc. in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

169% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 13

23% more capital invested

Capital invested by funds: $914M → $1.13B (+$213M)

16% more funds holding

Funds holding: 137159 (+22)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 52

51% less call options, than puts

Call options by funds: $1.1M | Put options by funds: $2.24M

Holders
159
Holders Change
+22
Holders Change %
+16.06%
% of All Funds
3.64%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
35
Increased
46
Reduced
52
Closed
13
Calls
$1.1M
Puts
$2.24M
Net Calls
-$1.14M
Net Calls Change
-$1.28M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS AM
101
UBS AM
Illinois
$580K +$221K +5,968 +68%
Holocene Advisors
102
Holocene Advisors
New York
$575K +$543K +14,694 New
JMPWA
103
JP Morgan Private Wealth Advisors
California
$537K
DTL
104
Dynamic Technology Lab
Singapore
$535K +$70.1K +1,896 +16%
AIM
105
Alambic Investment Management
California
$534K -$126K -3,415 -20%
VOYA Investment Management
106
VOYA Investment Management
Georgia
$521K
FFA
107
First Foundation Advisors
California
$508K +$480K +12,978 New
FQ
108
First Quadrant
California
$489K +$462K +12,494 New
US Bancorp
109
US Bancorp
Minnesota
$486K -$26.2K -710 -5%
GAM
110
Gotham Asset Management
New York
$468K +$442K +11,945 New
VF
111
Virtu Financial
New York
$466K +$171K +4,617 +63%
PPA
112
Parametric Portfolio Associates
Washington
$459K -$82.8K -2,240 -16%
FMT
113
First Mercantile Trust
Tennessee
$454K -$21.4K -578 -5%
MLICM
114
Metropolitan Life Insurance Company (MetLife)
New York
$447K
PIM
115
Partner Investment Management
California
$437K -$5.99K -162 -1%
BCM
116
BlueCrest Capital Management
Jersey
$426K -$90.4K -2,446 -18%
WMSA
117
Weiss Multi-Strategy Advisers
New York
$393K -$368K -9,966 -50%
SWP
118
Stratos Wealth Partners
Ohio
$376K -$3.7K -100 -1%
Commonwealth Equity Services
119
Commonwealth Equity Services
Massachusetts
$357K -$18.5K -500 -5%
NSEDCP
120
NJ State Employees Deferred Compensation Plan
New Jersey
$352K
DT
121
Diversified Trust
Tennessee
$335K
ARTA
122
A.R.T. Advisors
New York
$330K +$313K +8,455 New
XK
123
Xact Kapitalforvaltning
Sweden
$301K
JP Morgan Chase
124
JP Morgan Chase
New York
$294K -$79.4K -2,149 -22%
Parallax Volatility Advisers
125
Parallax Volatility Advisers
California
$257K +$243K +6,567 New

CSII Hedge Fund Activity: Q3 2018 in Review

159 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2018, worth a combined $1.13B — up 23% from $914M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new CSII positions and 13 closed out — a net gain of 22 holders — while 46 added to existing stakes and 52 trimmed.

The largest buyer was Brown Capital Management, adding an estimated $22.3M. The largest seller was Camber Capital Management, exiting entirely with an estimated $53.3M sold.

  • 159 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2018, up from 137 in Q2 2018.
  • Funds reported $1.13B of Cardiovascular Systems, Inc. stock for Q3 2018, up 23% quarter-over-quarter.
  • 35 funds opened new Cardiovascular Systems, Inc. positions in Q3 2018 and 13 closed out, a net change of +22 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2018 was Brown Capital Management, an estimated $22.3M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2018 was Camber Capital Management, an estimated $53.3M sold.

Based on aggregated 13F filings for Q3 2018.